Loading provider…
Loading provider…
Neurology Physician in Tyler, TX
NPI: 1184739641Primary Practice Location
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
1000 S Beckham Ave, Tyler, TX
Primary Employer
Etmc Physician Group Inc.
uthealtheasttexas.com
HQ Phone
Get MD George's Phone Numberphone_androidMobile
Get MD George's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2000 - 2025
MA State Medical License
1993 - 2002
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
Residency • Neurology
1990 - 1994
Boston University Medical Center
Internship • Internal Medicine
1989 - 1990
Boston University School Of Medicine
bumc.bu.edu
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 593 | 907 |
| 2 | 93886Ultrasound scanning of head and neck vessel blood flow (inside the brain) | 194 | 196 |
| 3 | 93880Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | 173 | 175 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 170 | 170 |
| 5 | 93892Ultrasound scanning for blood clot detection in head and neck vessel blood flow (inside the brain) | 83 | 83 |
Dystonia as a presenting feature of the 3243 mitochondrial DNA mutation.
Authors: Sudarsky, L, Plotkin, G M, Logigian, E L, Johns, D R
Journal: Mov Disord
The cutaneous silent period is mediated by spinal inhibitory reflex.
Authors: Logigian, E L, Plotkin, G M, Shefner, J M
Journal: Muscle Nerve
Electromyography: do the diagnostic ends justify the means?
Authors: Milind Kothari
Journal: Arch Phys Med Rehabil
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Pimavanserin 20 mg, DRUG: Pimavanserin 34 mg